Introduction
FIP member organisations will present their best initiatives and challenges.
Programme
08:00 – 08:05 | Introduction by the chair |
08:05 – 08:25 | MOTU-0201 – CT-Luso: Ethics and regulatory capacity building partnership for clinical trials in Portuguese-speaking African countries Mr Helder Mota Filipe CT-Luso is a capacity-building project aimed at enhancing ethical and regulatory frameworks for conducting clinical trials across Portuguese-speaking African countries, including Angola, Cape Verde, Guinea-Bissau, Mozambique, São Tomé and Príncipe, and Portugal. This initiative, a continuation of the BERC-Luso project focuses on improving partner countries’ abilities to host, collaborate on, and lead clinical trials in accordance with international biomedical practices. The session will present CT-Luso’s objectives, methodologies, milestones, and the outcomes achieved thus far, demonstrating its impact on the development of the involved countries. |
08:25 – 08:45 | MOTU-0202 – Innovating for sustainable change – empowering AMS leaders in low- and middle-income countries Ms Victoria Rutter This session will focus on the Commonwealth Partnerships for Antimicrobial Stewardship (CwPAMS) and its African Leadership Fellowship in Antimicrobial Stewardship (ALF-A), highlighting their role in enhancing pharmacists’ leadership skills and advancing patient outcomes. The presentation will discuss how these initiatives enable pharmacists, especially in low- and middle-income countries (LMICs), to lead sustainable antimicrobial stewardship (AMS) improvement projects, addressing the substantial challenges in AMS in these regions. Through global partnerships and the ALF-A fellowship, pharmacists have been empowered to become AMS leaders within their countries, driving impactful changes and innovations in AMS practices. |